Middle-aged and older adults AOD 9604 can offer a means of weight management without interfering with growth hormone pathways, giving it an advantage for older patients
Neuroprotection and Cognitive Support Emerging studies highlight BPC-157s potential to support neurological health
It is primarily used to treat pyridoxine deficiency, including cases resulting from inadequate dietary intake or drug-induced deficiencies
Peptide Vials (Retatrutide, 10 mg each): 12 weeks (Standard to 6 mg): 5 vials 24 weeks (Standard to 8 mg): 15 vials 12 weeks (Aggressive to 8 mg): 6 vials Insulin Syringes (U-100, 1 mL capacity): Per week: 12 syringes (depending on dose
Peptide therapy: Body Protection Compound 157 (BPC-157) and other peptides, such as Thymosin Beta and Sermorelin, can help to improve healing, accelerate joint recovery, and build resilience